Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Douglas A. McIntyre | Sep 23, 2008 at 11:07 AM EDT

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps…

Douglas A. McIntyre | Sep 23, 2008 at 2:51 AM EDT

Media Digest 9/23/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, Wilbur Ross say the bailout package does not address the core of problem which is mortgage payments.…

Douglas A. McIntyre | Sep 15, 2008 at 9:26 AM EDT

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex,…

Douglas A. McIntyre | Sep 11, 2008 at 10:03 AM EDT

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its…

Douglas A. McIntyre | Sep 10, 2008 at 8:21 AM EDT

Day Trader Alert: ImClone Systems (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The…

Douglas A. McIntyre | Aug 5, 2008 at 2:40 AM EDT

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

According to Reuters, large Yahoo! (YHOO) holder Capital Research want to know whether vote counts from the company’s annula meeting…

Douglas A. McIntyre | Aug 4, 2008 at 8:21 AM EDT

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…

Douglas A. McIntyre | Aug 1, 2008 at 2:50 AM EDT

Media Digest 8/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, GM (GM) is expected to post a huge loss. Reuters reports that oil company profits rose, but…

Douglas A. McIntyre | Jul 31, 2008 at 6:59 AM EDT

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a…

Douglas A. McIntyre | Jul 16, 2008 at 7:42 AM EDT

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating…

Douglas A. McIntyre | Jun 20, 2008 at 2:21 PM EDT

52-Week Low Club (WTR, BMY, CELL, DDS, EK, EXPE, GCI, GE, HST, NOK, PFE, Q, VLO, WY, WGO)

If you thought this was a bad day for the market with the DJIA trading well under that 12,000 psychological…

Douglas A. McIntyre | Jun 4, 2008 at 6:53 AM EDT

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

These are ten of the analyst calls we are focusing on this Wednesday morning in pre-market trading: Bristol-Myers (NYSE: BMY)…

Douglas A. McIntyre | Apr 28, 2008 at 11:20 AM EDT

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination…

Douglas A. McIntyre | Apr 24, 2008 at 7:03 AM EDT

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Bristol-Myers Squibb Company (NYSE: BMY) came out with earnings at $0.35 EPS and reaffirmed 2008 guidance of $1.36 to $1.46…

Douglas A. McIntyre | Apr 3, 2008 at 8:27 AM EDT

Medarex Says Forget Pfizer, Its Own Melanoma Study Continues (MEDX, PFE, BMY)

Medarex, Inc. (NASDAQ: MEDX) wants to clarify a few issues regarding the study halt from Pfizer (NYSE: PFE) this week…

1 … 35 36 37 38 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

Media Digest 9/23/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Day Trader Alert: ImClone Systems (IMCL, BMY)

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Media Digest 8/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

52-Week Low Club (WTR, BMY, CELL, DDS, EK, EXPE, GCI, GE, HST, NOK, PFE, Q, VLO, WY, WGO)

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Medarex Says Forget Pfizer, Its Own Melanoma Study Continues (MEDX, PFE, BMY)

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

Media Digest 9/23/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Day Trader Alert: ImClone Systems (IMCL, BMY)

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Media Digest 8/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

52-Week Low Club (WTR, BMY, CELL, DDS, EK, EXPE, GCI, GE, HST, NOK, PFE, Q, VLO, WY, WGO)

Top 10 Pre-Market Analyst Calls (BMY, MAR, MS, NRG, OMRI, SNCR, TRMB, TSN, MTN, XNPT)

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Medarex Says Forget Pfizer, Its Own Melanoma Study Continues (MEDX, PFE, BMY)

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Featured Reads

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk